Merck
FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 26, 2017
Zoster Vaccine Reduces Serious Shingles Complications in Seniors, Yet Remains Underused
Despite the fact that Merck’s Zostavax shingles vaccine provides seniors with high rates of protection from ...
APRIL 20, 2017
Load more